Plant Project Evonik Expands Capacities for Isophorone and Derivatives
German speciality chemcals company Evonik boosts its global production capacities for isophorone (IP) and isophorone diamine (IPD) with an € 100 million dollar investment in Shanghai. There, the company builds a new production site, scheduled to go onstream in 2014...
Shanghai/PR China – “We're investing in China, because we are committed to the growth region Asia. As a world leader in isophorone-based products, we will continue to further consolidate and expand our position in this chemistry," says Dr. Ulrich Küsthardt, President of Evonik’s Coating & Additives Business Unit.
The company underlined its strategy to establish a presence in proximity to customers in key growth areas, such as Asia: “Our aim in building the plants in Shanghai—at the company’s existing multi-user site—is to supply our Asian customers with the same high-quality products they are used to from our plants in Europe and the USA, now from a plant in the region," says Gerd Brand, Senior Vice President and Head of Crosslinkers Business Line.